Clinical trials
Phase 1/2 Thrombocythemia, Essential trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 3 |
| 2005 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2019 | 3 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 4 |
| M.D. Anderson Cancer Center | 2 |
| Asan Medical Center | 1 |
| Cancer Treatment Centers of America | 1 |
| Constellation Pharmaceuticals | 1 |
| Inge Marie Svane | 1 |
| Italfarmaco | 1 |
| Jubilant Therapeutics Inc. | 1 |
| Mayo Clinic | 1 |
| NS Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocythemia, Essential | 23 |
| Myeloproliferative Disorders | 20 |
| Polycythemia Vera | 20 |
| Primary Myelofibrosis | 19 |
| Leukemia, Myeloid, Acute | 12 |
| Myelodysplastic Syndromes | 11 |
| Leukemia | 10 |
| Leukemia, Myelomonocytic, Chronic | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 9 |
| Leukemia, Neutrophilic, Chronic | 8 |
Trials
Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.